Special Report: The Lab Kickback Risks of “Freebies”
How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
How to avoid six common compliance risks involving free supplies, equipment, software, and other non-monetary compensation
To ensure proper Medicare Part B billing and coding, your billing staff must be aware of all 22 of the newly recognized PLA codes.
Proper usage of ABN-related modifiers is a significant issue that has a direct impact on your lab’s reimbursement and compliance.
In this month’s roundup, three cases—including two whistleblower lawsuits and one workplace discrimination case—get dismissed.
Lab leaders must be able to make a sound assessment of both the costs and benefits, and the liability risks involved.
Labs have a duty to inquire into what their billing company is up to and whether it complies with all applicable regulations.
Recent Advisory Opinion sheds light on offering patients financial assistance so they can receive the provider’s products and services.
A code of conduct for sales and marketing staff is essential to allow staff to do their jobs while avoiding liability risk.
How to explain the current state of EKRA to your lab executives.
In this month’s roundup of cases involving labs, Labcorp gets one lawsuit tossed and settles another.
The first phase in protecting your staff is to carry out an exposure determination to figure out which of your workers are at risk.